Handelsavisen
prelaunch
Companies Financials EXPO.TA
EX
EXPO.TA TASE (Tel Aviv) Banks

Expo.Ta

$7 301,00
Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
1,49 %
Op margin
ROE
12,2 %
Net margin
24,0 %
Debt / equity
2,32
Beta
52w range
Volume
Day range
Prev close
$64,57
Open
Next earnings
2026-10-28
Ex-dividend
TR 1Y
About

EXPO.TA is a financial services company operating in the banking industry, generating revenue primarily through net interest income and fee-based services.

Business. EXPONENT INC (EXPO) is an IT services and consulting firm that provides IT consulting and other services. The company is headquartered in the United States and is listed on the Nasdaq stock exchange. Specific details regarding its operating segments and geographic revenue mix are not available.

Classification92 %
SectorFinancials
Business sectorBanking & Investment Services
IndustryBanks
Generated · model-assisted
Sell-side consensus
BUY4 analysts
3 buy1 hold0 sell
Avg 12m price target81,00

Analyst recommendations

4 analysts · consensus Buy
Buy3
Hold1
Sell0
12-month price target
81,00
Consensus of sell-side coverage.
Upcoming events
  • DividendDividend USD 0.31/sh2026-09-18
  • EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
Buy
4 analysts · indicative
Ownership
First Trust Advisors L.P.
largest disclosed fund holder
Profitability
12,2 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning EXPO.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials · THIS SECTOR−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to EXPO.TA. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Company
    • DividendDividend USD 0.31/sh2026-09-18
    • EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
    • Peers
    • DividendDividend USD 1.75/sh2026-09-25 · Bank of America (BAC)
    • EarningsQ3 2026 earnings (expected)2026-10-13 · estimated · JPMorgan Chase (JPM)
    • EarningsQ3 2026 earnings (expected)2026-10-13 · estimated · Citigroup (C)
    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR
    • Congressional trades
    • CongressLisa McClain — Exponent, Inc. - Common Stock2025-09-11 · Republican · MI · Sale · $1,001 - $15,000
    • CongressLisa McClain — Exponent, Inc. - Common Stock2025-08-13 · Republican · MI · Purchase · $1,001 - $15,000

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    EXPONENT INC (EXPO) is an IT services and consulting firm that provides IT consulting and other services. The company is headquartered in the United States and is listed on the Nasdaq stock exchange. Specific details regarding its operating segments and geographic revenue mix are not available.

    Classification92 %
    SectorFinancials
    Business sectorBanking & Investment Services
    IndustryBanks
    AI synthesis
    GENERATED

    The company maintains a debt-to-equity ratio of 2.32, indicating a relatively high leverage position compared to the industry median of 1.85. Its liquidity position is assessed as medium, with a negative net cash position after subtracting total debt. Free cash flow of 165.7 million ILS supports operational flexibility, though capital expenditures of -122.5 million ILS suggest asset disposals or reduced investment in physical infrastructure.

    Profitability metrics show a return on equity of 12.23%, which is above the industry median of 9.8%, but a return on assets of 0.68% lags behind the median of 1.2%. This suggests the company is generating strong returns for shareholders but is less efficient in utilizing its asset base to generate profit.

    Geographic and segment exposure is not disclosed in the available data, but the company's revenue concentration is inferred to be moderate given the absence of material segment or regional breakdowns. This lack of transparency may obscure potential risks from overreliance on a single market or product line.

    Growth trajectory is not explicitly outlined in the data, but the company's net income of 156.9 million ILS and revenue of 652.8 million ILS suggest stable operations. The absence of forward-looking guidance or revenue growth projections limits the ability to assess future performance.

    Risk factors include a medium liquidity risk due to the negative net cash position and a debt-to-equity ratio above the industry median. Dilution risk is assessed as low, with no significant changes in shares outstanding between basic and diluted measures. No recent events or filings are disclosed that would indicate material changes in the company's risk profile.

    Recent events and filings are not disclosed in the available data, which limits the ability to assess any material developments that may impact the company's operations or financial position. The absence of transcript data or regulatory filings suggests a need for further investigation into the company's recent activities.

    Key takeaways
    • EXPO.TA generates strong returns for shareholders with a return on equity of 12.23%, but its return on assets of 0.68% is below the industry median.
    • The company's debt-to-equity ratio of 2.32 indicates a leveraged capital structure, which may increase financial risk.
    • Free cash flow of 165.7 million ILS provides some liquidity cushion, but the negative net cash position after debt suggests reliance on external financing.
    • The absence of detailed segment and geographic exposure data limits the ability to assess revenue concentration risks.
    • "margin_outlook_rationale": "The company's margin outlook is stable, supported by strong return on equity but constrained by low return on assets.",
    • "rd_outlook_rationale": "No specific R&D outlook is disclosed, but the company's capital expenditures suggest a focus on asset optimization rather than innovation.",

    Bull / Bear case

    Generated · model-assisted
    BULL CASE · 3

    Exponent generated $137.6 million in free cash flow for FY2024, demonstrating strong cash generation capabilities.

    Net income grew at a 4.2% CAGR from FY2023 to FY2025, indicating consistent profitability expansion over time.

    With a debt-to-equity ratio of 0.99, Exponent maintains low leverage and a healthy 2.4 current ratio.

    BEAR CASE · 3

    Exponent faces medium dilution risk, which could potentially reduce existing shareholders' ownership percentage and earnings per share.

    Revenue declined by 4.0% year-over-year in the latest period, signaling potential headwinds in top-line growth.

    Operating income decreased by 0.2% year-over-year, suggesting slight pressure on core operational profitability despite revenue trends.

    In focus — financials by report

    Valuation

    Market price
    $7 301,00
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    $1.28B
    Net cash
    -$2.98B
    Current ratio
    Debt / equity
    2.3
    ROA
    0.7%
    ROE
    12.2%
    Cash conversion
    42.0%
    CapEx / revenue
    -18.8%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Engineering and Other Scientific84,9 %
    disclosed · sec_xbrl · 2026-01-02
    Environmental and Health15,1 %
    disclosed · sec_xbrl · 2026-01-02

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Next quarternear-term
    Earnings · next quarterconf 50 %
    EPS
    Consensus EPS
    2,30
    Predicted surprise
    -0,04
    Beat probability
    50 %
    Analysts
    4
    Other metrics
    Revenue
    no estimate
    Segment revenue
    no estimate
    Margin
    no estimate
    Segment margin
    no estimate
    revision ratio 0,02 · as of 2026-08-01 · Earnings Surprise V1
    Period note: consensus is not fiscal-period-aligned at source — read as consensus vs the last reported actual, not a calibrated same-quarter surprise.
    Segment revenue · next quarter
    No quarterly segment estimate
    Segment data is reported at full-fiscal-year granularity only — no quarterly segment split is forecast (a quarterly figure is never inferred from the annual). See the full-fiscal-year segment-revenue card below.
    Full fiscal year~1 year ahead
    Segment-revenue forecast · full fiscal year · native currency
    • Engineering & Scientific InstrumentsFY2027 — next full year (forecast) · projected off FY2026 close, as of 2026-01-02 · conf —504,1MFORECAST
    • Environmental & Health SolutionsFY2027 — next full year (forecast) · projected off FY2026 close, as of 2026-01-02 · conf —89,9MFORECAST
    • Engineering & Scientific InstrumentsFY2026 — reported · conf —479,2MREPORTED
    • Engineering & Scientific InstrumentsFY2025 — reported · conf —456,1MREPORTED
    • Environmental & Health SolutionsFY2025 — reported · conf —91,7MREPORTED
    • Environmental & Health SolutionsFY2026 — reported · conf —90,8MREPORTED
    Model estimate of reported / forward segment revenue in issuer-native currency. Confidence shown where the model calibrated it; "—" where not (never inferred).
    Probabilistic model output — not investment advice. · generated 2026-08-04

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    Low$72,00
    Mean$81,00
    Median$81,00
    High$90,00
    Spot$7 301,00
    −98.9 %implied to mean12-month sell-side price targets · ▲ spot

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Net Margin24,0 %Below median
    ROE12,2 %Above P75
    Capex / Rev-18,8 %Bottom quartile
    D/E2,32Bottom quartile
    Cash Conv0,42Below median

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    Derivative transactions

    Net acquired 42 717 sh18 exercises · 15 grants14 insiders
    • Corrigan CatherineDirector, Chief Executive Officer · Non-Qualified Stock Option (right to buy) → Common StockDisposed 12 665 @ $37,45exercise · 2026-07-28
    • Corrigan CatherineDirector, Chief Executive Officer · Non-Qualified Stock Option (right to buy) → Common StockDisposed 2 379 @ $29,05exercise · 2026-07-15
    • Corrigan CatherineDirector, Chief Executive Officer · Incentive Stock Option (right to buy) → Common StockDisposed 7 872 @ $25,41exercise · 2026-06-25
    • Corrigan CatherineDirector, President & CEO · Non-Qualified Stock Option (right to buy) → Common StockDisposed 3 225 @ $25,41exercise · 2026-06-15
    • Corrigan CatherineDirector, President & CEO · Non-Qualified Stock Option (right to buy) → Common StockDisposed 2 380 @ $29,05exercise · 2026-06-15
    • Lindstrom CarolDirector · Restricted Stock Units → Common StockAcquired 2 859grant · 2026-06-04
    • Brown George H.Director · Restricted Stock Units → Common StockAcquired 2 859grant · 2026-06-04
    • RICHARDSON KAREN ADirector · Restricted Stock Units → Common StockAcquired 2 859grant · 2026-06-04
    • Zumwalt DebraDirector · Restricted Stock Units → Common StockAcquired 2 859grant · 2026-06-04
    • RICHARDSON KAREN ADirector · Restricted Stock Units → Common StockDisposed 2 009exercise · 2026-06-03
    • Brown George H.Director · Restricted Stock Units → Common StockDisposed 2 009exercise · 2026-06-03
    • JOHNSTON PAUL RDirector · Restricted Stock Units → Common StockDisposed 2 009exercise · 2026-06-03
    • Zumwalt DebraDirector · Restricted Stock Units → Common StockDisposed 2 009exercise · 2026-06-03
    • Lindstrom CarolDirector · Restricted Stock Units → Common StockDisposed 2 009exercise · 2026-06-03
    • Corrigan CatherineDirector, President & CEO · Non-Qualified Stock Option (right to buy) → Common StockDisposed 3 226 @ $25,41exercise · 2026-05-15
    • Corrigan CatherineDirector, President & CEO · Non-Qualified Stock Option (right to buy) → Common StockDisposed 2 380 @ $29,05exercise · 2026-05-15
    • Corrigan CatherineDirector, President & CEO · Non-Qualified Stock Option (right to buy) → Common StockDisposed 2 380 @ $29,05exercise · 2026-04-15
    • Corrigan CatherineDirector, President & CEO · Non-Qualified Stock Option (right to buy) → Common StockDisposed 3 225 @ $25,41exercise · 2026-04-15
    • Pye JohnVP Global Offices & Innovation · Non-Qualified Stock Option (right to buy) → Common StockAcquired 14 992 @ $66,56grant · 2026-04-06
    • Pye JohnVP Global Offices & Innovation · Incentive Stock Option (right to buy) → Common StockAcquired 6 008 @ $66,56grant · 2026-04-06
    • Corrigan CatherineDirector, President & CEO · Non-Qualified Stock Option (right to buy) → Common StockDisposed 3 226 @ $25,41exercise · 2026-03-16
    • Corrigan CatherineDirector, President & CEO · Non-Qualified Stock Option (right to buy) → Common StockDisposed 2 380 @ $29,05exercise · 2026-03-16
    • Kundert BrianChief Human Resources Officer · Restricted Stock Units → Common StockAcquired 3 564grant · 2026-03-13
    • Pye JohnVP Global Offices & Innovation · Restricted Stock Units → Common StockAcquired 5 938grant · 2026-03-13
    • Rakow JosephGroup Vice President · Restricted Stock Units → Common StockAcquired 10 688grant · 2026-03-13

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Capex To Revenue
      capital_expenditure / revenue
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    Source documents
    • EXPO.TA Market data — financials · 2026-05-27

    Ownership & reference

    Top holders

    • First Trust Advisors L.P.Investment Managers · as of 2026-03-310,04 %$63M
    • AQR Capital Management, LLCInvestment Managers · as of 2026-03-310,03 %$64M
    • BlackRock Institutional Trust Company, N.A.Investment Managers · as of 2024-06-300,01 %$569M
    • Dimensional Fund Advisors, L.P.Investment Managers · as of 2026-03-310,01 %$60M
    • EATON VANCE MANAGEMENTInstitutional Investor · as of 2022-09-300,01 %$0M
    • Raymond James & Associates, Inc.Brokerage Firms · as of 2026-03-310,01 %$26M
    • Wells Fargo AdvisorsBrokerage Firms · as of 2026-03-310,01 %$40M
    • Geode Capital Management, L.L.C.Investment Managers · as of 2026-03-310,01 %$108M
    • Goldman Sachs Asset Management, L.P.Investment Managers · as of 2026-03-310,01 %$51M
    • Principal Global Investors (Equity)Investment Managers · as of 2026-03-310,01 %$12M
    • Northern Trust Investments, Inc.Investment Managers · as of 2026-03-310,01 %$43M
    • Invesco QQQ TrustFunds · as of 2026-03-310,01 %$37M
    • Bank of New York Mellon CorpInstitutional Investor · as of 2026-03-310,01 %$30M
    • Charles Schwab Investment Management, Inc.Investment Managers · as of 2026-03-310,01 %$34M
    • Vanguard Capital Management, LLCInvestment Managers · as of 2025-12-310,01 %$357M
    • State Street Investment Management (US)Investment Managers · as of 2026-03-310,00 %$123M
    • Morgan Stanley Smith Barney LLCInvestment Managers · as of 2026-03-310,00 %$70M
    • UBS Financial Services, Inc.Investment Managers · as of 2026-03-310,00 %$23M
    • Nuveen LLCInvestment Managers · as of 2024-12-310,00 %$13M
    • American Century Investment Management, Inc.Investment Managers · as of 2026-03-310,00 %$5M
    • Victory Capital Management Inc.Investment Managers · as of 2026-03-310,00 %$3M
    • AllianceBernstein L.P.Investment Managers · as of 2026-03-310,00 %$6M
    • AMERIPRISE FINANCIAL INCInstitutional Investor · as of 2026-03-310,00 %$8M
    • LPL Financial LLCInvestment Managers · as of 2026-03-310,00 %$4M
    • JANUS HENDERSON GROUP PLCInstitutional Investor · as of 2026-03-310,00 %$1M
    • T. Rowe Price Associates, Inc.Investment Managers · as of 2026-03-310,00 %$0M
    • Franklin Advisers, Inc.Investment Managers · as of 2026-03-310,00 %$1M
    • PNC Investments LLCInvestment Managers · as of 2026-03-310,00 %$1M
    • FMR LLCInstitutional Investor · as of 2026-03-310,00 %$2M
    • JONES FINANCIAL COMPANIES LLLPInstitutional Investor · as of 2026-03-310,00 %$0M

    Insider activity

    Net selling0 buys · 13 sellsnet -$1,6M11 insiders · last 365d
    • Corrigan CatherineDirector, Chief Executive Officer · Common StockOther 12 665 @ $37,45$474K · 2026-07-28
    • Corrigan CatherineDirector, Chief Executive Officer · Common StockOther 2 379 @ $29,05$69K · 2026-07-15
    • Corrigan CatherineDirector, Chief Executive Officer · Common StockSold 1 737 @ $62,78$109K · 2026-07-15
    • Corrigan CatherineDirector, Chief Executive Officer · Common StockOther 7 872 @ $25,41$200K · 2026-06-25
    • Corrigan CatherineDirector, President & CEO · Common StockOther 2 380 @ $29,05$69K · 2026-06-15
    • Corrigan CatherineDirector, President & CEO · Common StockSold 1 793 @ $57,13$102K · 2026-06-15
    • Corrigan CatherineDirector, President & CEO · Common StockOther 3 225 @ $25,41$82K · 2026-06-15
    • Corrigan CatherineDirector, President & CEO · Common StockSold 2 326 @ $57,13$133K · 2026-06-15
    • JOHNSTON PAUL RDirector · Common StockOther 2 009 · 2026-06-03
    • RICHARDSON KAREN ADirector · Common StockOther 2 009 · 2026-06-03
    • Zumwalt DebraDirector · Common StockOther 2 009 · 2026-06-03
    • Lindstrom CarolDirector · Common StockOther 2 009 · 2026-06-03
    • Brown George H.Director · Common StockOther 2 009 · 2026-06-03
    • James Bradley AGroup Vice President · Common StockSold 2 000 @ $57,47$115K · 2026-05-26
    • Reiss RichardGroup Vice President · Common StockSold 1 672 @ $58,65$98K · 2026-05-19
    • Corrigan CatherineDirector, President & CEO · Common StockSold 1 827 @ $54,06$99K · 2026-05-15
    • Corrigan CatherineDirector, President & CEO · Common StockSold 2 367 @ $54,06$128K · 2026-05-15
    • Corrigan CatherineDirector, President & CEO · Common StockOther 2 380 @ $29,05$69K · 2026-05-15
    • Corrigan CatherineDirector, President & CEO · Common StockOther 3 226 @ $25,41$82K · 2026-05-15
    • Sala JosephGroup Vice President · Common StockSold 2 066 @ $56,66$117K · 2026-05-13
    • Rakow JosephGroup Vice President · Common StockSold 2 945 @ $54,66$161K · 2026-05-13
    • Corrigan CatherineDirector, President & CEO · Common StockSold 2 212 @ $67,70$150K · 2026-04-15
    • Corrigan CatherineDirector, President & CEO · Common StockSold 1 697 @ $67,70$115K · 2026-04-15
    • Corrigan CatherineDirector, President & CEO · Common StockOther 3 225 @ $25,41$82K · 2026-04-15
    • Corrigan CatherineDirector, President & CEO · Common StockOther 2 380 @ $29,05$69K · 2026-04-15

    Short positioning

    2.9Mshares short+1.9% vs prior
    5.87days to cover
    40.8%short of daily vol
    56fails-to-deliver
    as of 2026-07-15 · short-interest report (free)

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    EXPO.TACanonical
    TASE (Tel Aviv) · USD

    Intel & risk

    PredictorBeat prob50 %Surprise-0,04Full forecast →
    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.
    Relationship graph
    EXPOJPMBACCBanks
    This companyPeerSector

    Evidence & claims

    From filings & derived data
    • EPS (basic) (YoY) (2026-01-02 vs 2025-01-03): -2.3%Derived (calculated)
    • Current ratio (FY 2026-01-02): 2.40xDerived (calculated)
    • Debt-to-equity (FY 2026-01-02): 0.99xDerived (calculated)
    • Cash & equivalents (YoY) (2026-01-02 vs 2025-01-03): -14.3%Derived (calculated)
    • Capex (YoY) (2026-01-02 vs 2025-01-03): 35.3%Derived (calculated)
    • Total liabilities (YoY) (2026-01-02 vs 2025-01-03): 8.7%Derived (calculated)
    • Shareholders' equity (YoY) (2026-01-02 vs 2025-01-03): -7.3%Derived (calculated)
    • Revenue (YoY) (2026-01-02 vs 2025-01-03): 4.2%Derived (calculated)
    • Operating income (YoY) (2026-01-02 vs 2025-01-03): 0.2%Derived (calculated)
    • Operating cash flow (YoY) (2026-01-02 vs 2025-01-03): -8.9%Derived (calculated)
    • Net income (YoY) (2026-01-02 vs 2025-01-03): -2.7%Derived (calculated)
    • EPS (diluted) (YoY) (2026-01-02 vs 2025-01-03): -1.9%Derived (calculated)
    • Return on assets (FY 2026-01-02): 13.6%Derived (calculated)
    • Total assets (YoY) (2026-01-02 vs 2025-01-03): 0.0%Derived (calculated)
    • Net margin (FY 2026-01-02): 18.2%Derived (calculated)
    • Return on equity (FY 2026-01-02): 27.2%Derived (calculated)
    • Shareholders' equity (annual): USD 390.34MSEC XBRL filing
    • Capex (annual): USD 9.39MSEC XBRL filing
    • Pre-tax income (annual): USD 147.3MSEC XBRL filing
    • Operating cash flow (annual): USD 131.73MSEC XBRL filing
    • Revenue (annual): USD 582.01MSEC XBRL filing
    • Cash & equivalents (annual): USD 221.93MSEC XBRL filing
    • Total operating expenses (annual): USD 462.23MSEC XBRL filing
    • Net income (annual): USD 106.01MSEC XBRL filing
    Showing 24 of 60 surfaced claims.
    Atomic claims from regulatory filings and derived calculations. Provenance shown as source kind only.

    The Thread

    Everything we know, in order
    2026-10-28EVENTUpcomingQ3 2026 earnings (expected) estimated date
    2026-09-18EVENTUpcomingDividend USD 0.31/sh
    2026-07-30 00:00 UTCTRANSCRIPTEarnings call — Q3 2026
    2026-07-28INSIDERCorrigan Catherine transacted 12.7k sh — Director, Chief Executive Officer ~$474k
    2026-07-28INSIDERCorrigan Catherine disposed of 12.7k sh Non-Qualified Stock Option (right to buy) — Director, Chief Executive Officer
    2026-07-15INSIDERCorrigan Catherine transacted 2.4k sh — Director, Chief Executive Officer ~$69k
    2026-07-15INSIDERCorrigan Catherine sold 1.7k sh — Director, Chief Executive Officer ~$109k
    2026-07-15INSIDERCorrigan Catherine disposed of 2.4k sh Non-Qualified Stock Option (right to buy) — Director, Chief Executive Officer
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (365d)
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (365d)
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (365d)
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (365d)
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (365d)
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (365d)
    2026-06-28 03:45 UTCEARNINGSUpcomingForecast: fundamentals_forecast (365d)
    2026-06-28 03:45 UTCEARNINGSUpcomingForecast: fundamentals_forecast (365d)
    2026-06-25 00:00 UTCINSIDER22 insider transactions — 2026-06 · net buy $116k 12 derivative
    2026-06-25INSIDERCorrigan Catherine transacted 7.9k sh — Director, Chief Executive Officer ~$200k
    2026-06-25INSIDERCorrigan Catherine disposed of 7.9k sh Incentive Stock Option (right to buy) — Director, Chief Executive Officer
    2026-06-22 17:48 UTCNEWSEXPO 2027 volunteer recruitment surpasses 6,700 sign-ups → Strong early interest in the Belgrade event's workforce program signals robust public engagement ahead of the 2027 fair.
    2026-06-15INSIDERCorrigan Catherine sold 2.3k sh — Director, President & CEO ~$133k
    2026-06-15INSIDERCorrigan Catherine sold 1.8k sh — Director, President & CEO ~$102k
    2026-06-15INSIDERCorrigan Catherine transacted 3.2k sh — Director, President & CEO ~$82k
    2026-06-15INSIDERCorrigan Catherine transacted 2.4k sh — Director, President & CEO ~$69k
    2026-06-15INSIDERCorrigan Catherine disposed of 2.4k sh Non-Qualified Stock Option (right to buy) — Director, President & CEO
    2026-06-15INSIDERCorrigan Catherine disposed of 3.2k sh Non-Qualified Stock Option (right to buy) — Director, President & CEO
    2026-06-10FILINGFORM 8-K →
    2026-06-04INSIDERLindstrom Carol acquired 2.9k sh Restricted Stock Units — Director
    2026-06-04INSIDERZumwalt Debra acquired 2.9k sh Restricted Stock Units — Director
    2026-06-04INSIDERRICHARDSON KAREN A acquired 2.9k sh Restricted Stock Units — Director
    2026-06-04INSIDERBrown George H. acquired 2.9k sh Restricted Stock Units — Director
    2026-06-03INSIDERJOHNSTON PAUL R transacted 2.0k sh — Director
    2026-06-03INSIDERRICHARDSON KAREN A transacted 2.0k sh — Director
    2026-06-03INSIDERZumwalt Debra transacted 2.0k sh — Director
    2026-06-03INSIDERLindstrom Carol transacted 2.0k sh — Director
    2026-06-03INSIDERBrown George H. transacted 2.0k sh — Director
    2026-06-03INSIDERBrown George H. disposed of 2.0k sh Restricted Stock Units — Director
    2026-06-03INSIDERJOHNSTON PAUL R disposed of 2.0k sh Restricted Stock Units — Director
    2026-06-03INSIDERRICHARDSON KAREN A disposed of 2.0k sh Restricted Stock Units — Director
    2026-06-03INSIDERZumwalt Debra disposed of 2.0k sh Restricted Stock Units — Director
    Showing the 40 most recent of 70 entries.
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage